by McDermott + Bull | Nov 27, 2024 | Ken Dropiewski, Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski Article
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
by McDermott + Bull | Nov 26, 2024 | Noelle Swan, Article, Technology Article
I recently had the pleasure of sitting down with Brian Allen, a seasoned leader and the author of several books on Enterprise Security Risk Management (ESRM), where we discussed the profound changes driven by AI and digitalization that are transforming industries and...
by McDermott + Bull | Nov 21, 2024 | Article, Chris Bull, Chris Bull Article, Private Equity, Private Equity Article
The private equity world is undergoing a fundamental transformation in the way firms approach talent strategy and leadership development. A recent Harvard Business Review analysis reveals why the traditional PE playbook – focused primarily on financial engineering and...
by McDermott + Bull | Aug 16, 2024 | Aaron Griffin, Aaron Griffin Article, Article
Executive leader’s face a myriad of challenges in managing today’s dynamic workforce. Our Partners and Managing Directors in executive search and interim leaders interviewed 14 executive clients to uncover the major factors impacting one of the most common...
by McDermott + Bull | May 22, 2024 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus
Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
by McDermott + Bull | May 16, 2024 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
A few weeks ago, McDermott + Bull Interim Leaders and I hosted a small breakfast for C-Level executives in the life sciences sector. Simon Arkell, CEO and Co-Founder of Ryght AI, joined us as our keynote speaker to share his thoughts and insights on AI and its impact...
